Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancerGiacomo Oliveira, Ravindra Uppaluri, Ann Marie Egloff et al.|Science Immunology|2023Cited by 118
<i>TREX1</i> Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor ImmunityTetsuo Tani, David A. Barbie, Haritha Mathsyaraja et al.|Cancer Discovery|2024Cited by 98
Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer respondersLiye Zhou, Ravindra Uppaluri, Zexian Zeng et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 51
Personalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell CarcinomaGlenn J. Hanna, Eleni M. Rettig, Michael J. Dennis et al.|Clinical Cancer Research|2024Cited by 48
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung CancerRyohei Yoshida, David A. Barbie, Juan J. Miret et al.|Cancer Research|2022Cited by 38